• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Singh Sumit sold $8,056,695 worth of shares (198,806 units at $40.53), decreasing direct ownership by 22% to 705,252 units (SEC Form 4)

    5/15/25 4:44:06 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $CHWY alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Singh Sumit

    (Last) (First) (Middle)
    7700 WEST SUNRISE BOULEVARD

    (Street)
    PLANTATION FL 33322

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Chewy, Inc. [ CHWY ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    05/13/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 05/13/2025 S 50,743(1) D $40.09(2) 853,315 D
    Class A Common Stock 05/14/2025 S 146,102(1) D $40.67(3) 707,213 D
    Class A Common Stock 05/14/2025 S 1,961(1) D $41.02(4) 705,252 D
    Class A Common Stock 321,694(5) D
    Class A Common Stock 134,040(6) D
    Class A Common Stock 803,304(7) D
    Class A Common Stock 532,772(8) D
    Class A Common Stock 32,228(9) D
    Class A Common Stock 307,660(10) D
    Class A Common Stock 2,120(11) I By Spouse
    Class A Common Stock 22,121(12) I By Spouse
    Class A Common Stock 18,273(13) I By Spouse
    Class A Common Stock 60,625(14) I By Spouse
    Class A Common Stock 52,133(15) I By Spouse
    Class A Common Stock 51,735(16) I By Spouse
    Class A Common Stock 33,508(17) I By Spouse
    Class A Common Stock 66,316 I By Spouse
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on September 25, 2024.
    2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $40.00-$40.38, inclusive. The filing person undertakes to provide to Chewy, Inc., any security holder of Chewy, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 through 4 to this Form 4.
    3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $40.00-$40.99, inclusive.
    4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $41.00-$41.02, inclusive.
    5. Represents performance-based restricted stock units ("PRSUs") granted to the filing person. Each PRSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The PRSUs were initially granted on January 18, 2024 and the amount of PRSUs eligible for vesting was subject to certification of the satisfaction of certain performance conditions for the 2023 fiscal year by the Compensation Committee of the Board of Directors. On March 22, 2024, the Compensation Committee of the Board of Directors certified the achievement of the performance conditions for the PRSUs, which vest on February 1, 2026, subject to the filing person's continued employment with Chewy, Inc. through the vesting date.
    6. Represents restricted stock units ("RSUs") granted to the filing person on January 18, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 25% of these RSUs will vest on August 1, 2025, and 25% will vest each six-month anniversary thereafter, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date.
    7. Represents PRSUs granted to the filing person. Each PRSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The PRSUs were initially granted on April 4, 2024 and the amount of PRSUs eligible for vesting was subject to certification of the satisfaction of certain performance conditions for the 2024 fiscal year by the Compensation Committee of the Board of Directors. On March 26, 2025, the Compensation Committee of the Board of Directors certified the achievement of the performance conditions for the PRSUs, which vest on February 1, 2027, subject to the filing person's continued employment with Chewy, Inc. through the vesting date.
    8. Represents RSUs granted to the filing person on April 4, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 7.4% will vest on August 1, 2025, 7.4% will vest on November 1, 2025, 18.9% will vest on December 1, 2025, and 7.4% will vest on February 1, 2026 and on each three-month anniversary thereafter, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date.
    9. Represents RSUs granted to the filing person on January 18, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 100% of these RSUs will vest on February 1, 2026, subject to the filing person's continued employment with Chewy, Inc. through the vesting date.
    10. Represents RSUs granted to the filing person on April 8, 2025. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 25% of these RSUs will vest on March 1, 2026, and 6.25% will vest on each three-month anniversary thereafter, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date.
    11. Represents RSUs granted to the filing person's spouse on April 7, 2022. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 50% of these RSUs will vest on August 1, 2025, and 50% will vest on February 1, 2026, subject to the filing person's spouse's continued employment with Chewy, Inc. through the applicable vesting date.
    12. Represents PRSUs granted to the filing person's spouse. Each PRSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The PRSUs were initially granted on April 6, 2023 and the amount of PRSUs eligible for vesting was subject to certification of the satisfaction of certain performance conditions for the 2023 fiscal year by the Compensation Committee of the Board of Directors. On March 22, 2024, the Compensation Committee of the Board of Directors certified the achievement of the performance conditions for the PRSUs, which vest on February 1, 2026, subject to the filing person's spouse's continued employment with Chewy, Inc. through the vesting date.
    13. Represents RSUs granted to the filing person's spouse on April 6, 2023 and June 26, 2023. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. With respect to 15,680 of the RSUs, 25% will vest on August 1, 2025, and 25% will vest each six-month anniversary thereafter, subject to the filing person's spouse continued employment with Chewy, Inc. through the applicable vesting date. With respect to 2,593 of the RSUs, 100% will vest on April 1, 2026, subject to the filing person's spouse's continued employment with Chewy, Inc. through the applicable vesting date.
    14. Represents PRSUs granted to the filing person's spouse. Each PRSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The PRSUs were initially granted on April 4, 2024 and August 5, 2024 and the amount of PRSUs eligible for vesting was subject to certification of the satisfaction of certain performance conditions for the 2024 fiscal year by the Compensation Committee of the Board of Directors. On March 26, 2025, the Compensation Committee of the Board of Directors certified the achievement of the performance conditions for the PRSUs, which vest on February 1, 2027, subject to the filing person's spouse's continued employment with Chewy, Inc. through the vesting date.
    15. Represents RSUs granted to the filing person's spouse on April 4, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 8.8% will vest on August 1, 2025, 8.8% will vest on November 1, 2025, 3.2% will vest on December 1, 2025, and 8.8% will vest on February 1, 2026 and on each three-month anniversary thereafter, subject to the filing person's spouse's continued employment with Chewy, Inc. through the applicable vesting date.
    16. Represents RSUs granted to the filing person's spouse on April 8, 2025. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 25% of these RSUs will vest on March 1, 2026, and 6.25% will vest on each three-month anniversary thereafter, subject to the filing person's spouse's continued employment with Chewy, Inc. through the applicable vesting date.
    17. Represents RSUs granted to the filing person's spouse on August 5, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 2.7% of these RSUs will vest on August 1, 2025, and 2.7% will vest on each three-month anniversary thereafter except for February 1, 2026, when 73% will vest, subject to the filing person's spouse's continued employment with Chewy, Inc. through the applicable vesting date.
    /s/ Da-Wai Hu, as Attorney-in-Fact for Sumit Singh 05/15/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CHWY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHWY

    DatePrice TargetRatingAnalyst
    6/9/2025$47.00Outperform → Neutral
    Mizuho
    6/5/2025$43.00Buy → Hold
    Jefferies
    3/24/2025Neutral
    Seaport Research Partners
    1/23/2025Hold → Buy
    Argus
    1/13/2025$34.00 → $47.00In-line → Outperform
    Evercore ISI
    1/6/2025$24.00 → $42.00Neutral → Outperform
    Mizuho
    1/3/2025Peer Perform → Outperform
    Wolfe Research
    12/5/2024Outperform → Neutral
    Exane BNP Paribas
    More analyst ratings

    $CHWY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Chewy Announces First Quarter 2025 Financial Results

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the first quarter of fiscal year 2025 ended May 4, 2025. Fiscal Q1 2025 Highlights: Net sales of $3.12 billion increased 8.3 percent year over year Gross margin of 29.6 percent decreased 10 basis points year over year Net income of $62.4 million, including share-based compensation expense and related taxes of $78.0 million Net margin of 2.0 percent decreased 30 basis points year over year Basic earnings per share of $0.15, consistent year over year Diluted earnings per share of $0.15, consistent year over year Adjusted EBITDA(1) of $

      6/11/25 7:05:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy CFO David Reeder to Depart Chewy, Company Reaffirms First Quarter Guidance

      Chewy, Inc. (NYSE:CHWY), a trusted destination for pet parents and partners everywhere, announced today that the Company's Chief Financial Officer, David Reeder, will be departing in several months to return to the semiconductor industry as a Chief Executive Officer. "We appreciate David's contributions during his time at Chewy and thank him for his leadership as we advanced our strategic, long-term growth initiatives," said Sumit Singh, Chief Executive Officer of Chewy. "As discussed on our March 26th earnings call, our long term plan remains intact, our business momentum remains strong, and we are reaffirming our guidance for the first quarter. David will remain as CFO through our next e

      5/12/25 7:30:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy Announces Fiscal First Quarter 2025 Financial Results Conference Call

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal first quarter 2025 financial results before the market opens on Wednesday, June 11, 2025. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcast can be accessed

      5/9/25 8:30:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Chewy downgraded by Mizuho with a new price target

      Mizuho downgraded Chewy from Outperform to Neutral and set a new price target of $47.00

      6/9/25 7:45:18 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy downgraded by Jefferies with a new price target

      Jefferies downgraded Chewy from Buy to Hold and set a new price target of $43.00

      6/5/25 7:33:11 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Seaport Research Partners initiated coverage on Chewy

      Seaport Research Partners initiated coverage of Chewy with a rating of Neutral

      3/24/25 7:44:34 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

      For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

      12/14/23 9:00:20 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Star James A bought $249,519 worth of shares (12,242 units at $20.38), increasing direct ownership by 9% to 141,790 units (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      12/18/23 4:09:39 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Star James A bought $300,992 worth of shares (15,353 units at $19.60), increasing direct ownership by 13% to 129,548 units (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      12/14/23 4:10:59 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary